Alopecia Market

Alopecia Market

Alopecia Market By Type, By Application, By End-Users, By Distribution Channel, Forecasts to 2027

Market Synopsis

The global alopecia market size was valued at USD 2,650.8 Million in 2019 and is forecasted to reach USD 5,250.8 Million by 2027 at a CAGR of 8.9%. The alopecia market is projected to experience rapid growth attributed to the prevalence of various disease types comprising alopecia areata, androgenetic alopecia, alopecia totalis, traction alopecia, and cicatricle alopecia. Factors such as increasing incidence of chronic diseases, rising cases of Polycystic Ovary Syndrome (PCOS), rise in the level of disposable income, and advancements in medical technology for delivering enhanced treatment.

Diseases such as thyroid disorders, cancer, lupus, muscular dystrophy, heavy metal poisoning, pituitary gland disease, sarcoidosis, syphilis in last-stage, and continuing chronic diseases may lead to alopecia. It has been found that about 65.0% of people receiving chemotherapy are likely to suffer from chemotherapy-induced hair loss. In comparison, the deployment of cancer treatment with molecularly targeted agents has been linked with hair loss rates up to a maximum of 60.0%.

Additionally, advancements in technology and usage of emerging therapeutics such as stem cells, cellular pathways, growth factors, and robotic hair transplant, for alopecia, provide ample opportunities to boost the market growth.

However, a low level of awareness about the condition may hamper the market’s growth in the forecast period.Type Insights

By type, alopecia areata accounted for the largest market share of over 31.0% of the alopecia market in 2019

Alopecia areata, a chronic, autoimmune disorder that affects growing hair follicles resulting in nonscarring focal hair loss, has global prevalence. In the US, it affects approximately 6.8 million individuals. In a large number of cases, this condition causes hairs to fall-out in various amounts ranging from small patches to severe hair loss. Occasionally, it may result in total hair loss on the scalp and the whole body in extreme conditions. The disease affects individuals regardless of their gender and age.

The disease’s likely occurrence is about 0.001% of the population and has a lifetime risk of around 2.0%. It may occur in people of all ages, including children and adults, and at more or less the same rate in the male and female population.

Application Insights

By application, men accounted for the largest market share 65.0% of the alopecia market in 2019

Alopecia/hair-loss in men caused several factors, including smoking, consumption of alcoholic beverages, stress, drug abuse, and genetics, among other factors. Male pattern baldness or androgenic alopecia, a hereditary cause of hair loss, may be triggered at any point in a man’s life, including adolescence.

As per a study conducted by the US National Library of Medicine (NLM), over 50.0% of the global male population beyond the age of 50 will experience male pattern baldness to a certain extent.

End-Users Insights

By end-users, dermatology clinics is likely to grow at the fastest rate of 9.5% in the forecast period

Dermatology clinics expert medical professionals trained for diagnosing conditions including skin (scalp) and hair. Dermatologists help find the root cause of hair problems and successfully cure hair-loss in several cases. The high market share of dermatology clinics is due to the rising number of surgeries associated with hair transplantation and restoration and the extensive usage of prescription drugs.

Dermatology clinics possess the expertise to prevent thinning of hairs and boost hair growth. In the US, the FDA has sanctioned minoxidil for the treatment of hair loss and is the only approved hair re-growth product. A dermatologist can incorporate minoxidil with other treatment methods to cure hair loss.

Regional Insights

By region, North America accounted for the largest market share of over 36.0% of the alopecia market in 2019

The North American region’s market dominance is due to the high alopecia incidence, advanced healthcare infrastructure, high per-capita income, and accessibility to innovative treatment options for hair loss. Increased investment in R&D and a rising number of patent approvals in the region are also causatives of market growth.

The market in the Asia Pacific region is projected to grow at the fastest rate of 10.0% in the forecast period attributed to increasing incidence of chronic disorders, growing awareness among the population, especially in people of the young generation, and a rise in the level of disposable income.

Major Companies and Market Share Analysis

The leading players in the alopecia market are equipped with enhanced production facilities and are involved in various R&D activities. A few leading players in the alopecia market include:

  • Johnson & Johnson Services Inc.
  • Cirrus Hair Centers
  • Cipla Inc.
  • Follica Inc.
  • Merck & Co. Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Convert Pharmaceuticals Inc.
  • GlaxoSmithKline PLC
  • Aclaris Therapeutics Inc.
  • HCell Inc.

In January 2020, Revian made an announcement about the receiving of a patent by the U.S. Patent & Trademark Office (USPTO) for the application of proprietary color light combinations for regenerating living body tissues such as including hair.

Scope Of Research


The market size value in 2019
USD 2,650.8 million

CAGR (2020 – 2027)

The revenue forecast in 2027
USD 5,250.8 million

Base year for estimation

Historical data

Forecast period

Quantitative units
Revenue in USD Billion, and CAGR from 2020 to 2027

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Type, application, end-users, Region

Regional scope

North America; Europe; Asia Pacific; Central & South America; MEA

Country scope

U.S.; Canada; Mexico; U.K.; Germany; France; Italy; Spain; China; India; Japan; South Korea; Brazil; Saudi Arabia; South Africa; Turkey

Key companies profiled

Johnson & Johnson Services Inc., Cirrus Hair Centers, Cipla Inc., Follica Inc., Merck & Co. Inc., Sun Pharmaceutical Industries Ltd., Concert Pharmaceuticals Inc., GlaxoSmithKline PLC, Aclaris Therapeutics Inc., and HCell Inc.

Customization scope

10 hrs of free customization and expert consultation

Segments Covered in the report


This report forecasts revenue growth at a global, regional & country level and provides an analysis of the market trends in each of the sub-segments from 2018 to 2027. The scope of the report can be defined as:

For the purpose of this report, Emergen Research has segmented the global alopecia market on the basis of type, application, end-users, distribution channel, and region:

  • Type Outlook (Revenue, USD Billion; 2017-2027) 
    • Alopecia Areata
    • Androgenetic Alopecia
    • Alopecia Totalis
    • Traction Alopecia
    • Cicatricle Alopecia
    • Others
  • Application Outlook (Revenue, USD Billion; 2017-2027) 
    • Male
    • Female
  • End-Users Outlook (Revenue, USD Billion; 2017-2027) 
    • Dermatology Clinics
    • Homecare Settings
    • Others
  • Distribution Channel Outlook (Revenue, USD Billion; 2017-2027) 
    • Prescription
    • OTC (Over-the-Counter)
  • Regional Outlook (Revenue, USD Billion; 2017-2027) 
    • North America

      1. U.S.
      2. Canada
      3. Mexico
    • Europe

      1. Germany
      2. UK
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific

      1. China
      2. Japan
      3. South Korea
      4. Rest of APAC
    • Latin America

      1. Brazil
      2. Rest of LATAM
    • MEA

      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

Alopecia Market By Type, By Application, By End-Users, By Distribution Channel, Forecasts to 2027


Recent Posts